News & Media

Dr. Reno Pontarollo, the current Chief Scientific Officer of Genome Prairie, will succeed Dr. David Gauthier as President and Chief Executive Officer on April 1, 2013.

Premier Greg Selinger awarded the Order of the Buffalo Hunt to Dr. Ian Smith

IH Systems announced a partnership with Dokuz Eylül University Hospital in Izmir, Turkey, to develop a total dose solution

Monteris closed on US$7.8 million in new financing. The total funding raised in 2012 approached US$16 million

Miraculins, PharmaChoice, and Pear Healthcare Solutions announced that PharmaChoice will be the first pharmacy network to introduce the PreVu® test in Ontario and Atlantic Canada

Assuming the biocomposite industry reaches its potential, Simon Potter envisions a future in which flax and hemp growers will receive true value for the fibres inside those crops.

Varizig was approved by the FDA to minimize chickenpox symptoms when administered within four days of exposure to the virus in high risk individuals.

London Drugs will be expanding its offering of the PreVu® Non-Invasive Skin Cholesterol Point of Care Test to all 76 physical pharmacy locations in more than 35 major markets throughout Western Canada.

Prairie Bio Energy Group (PBE Group) have signed a partnership with a multi-billion dollar Canadian organization, La Coop fédérée, enabling PBE Group to grow exponentially. PBE Group is approaching the point of full commercialization at their customized

RE$EARCH Info Source Inc. has released their findings for the 2012 Survey of Canada’s Top Research Hospitals.

If the level of interest from a round of pitches to the VA Angels investor group is any indication, Kelly Beaulieu is the emerging star of the province's innovation set.

Cangene and Amorfix Life Sciences established a collaboration for the identification and development of therapeutic antibodies against proprietary disease specific epitopes

The new programs will focus on strategic initiatives in innovation, competitiveness and market development to further strengthen the sector's capacity to grow and prosper.

TRTech announces that the company's brand name has been changed from TRLabs to support its evolution from an applied research organization to an organization that enables commercialization for its industry partners

A tragic outbreak of fungal meningitis in the U.S. has helped create a perfect storm of favourable market conditions for a Winnipeg manufacturer of robotic pharmacy equipment.

RIVA is ahead of competitors in overall performance, meeting business case expectations and customer satisfaction

Kane has received regulatory approval this month that should pave the way for it to launch its first two products on the market early in the new year.

XiteBio Technologies Inc. is pleased to announce the full commercial launch of XiteBio® PeasRhizo, a low-volume premium ready-to-use liquid pea & lentil inoculant, for spring 2013. Improved crop vigour and yield increases have consistently been reported

Priority actions in the strategy include building a new generation of clean, renewable hydro power, leading North America on energy efficiency, keeping rates low and growing renewable energy alternatives. Highlighted in the strategy is a biomass energy-su

Kane announced it has received Notification Number "NN.W33A" from the Low Risk Veterinary Health Products program for the marketing of StrixNB in Canada

Miraculins provided the market with a summary overview of its key operating, marketing and distribution accomplishments for PreVu®